text:
ARM Holdings Plc - Results For The Quarter Ended 31 March 2005
Dollar revenues* in Q1 2005 of $103.2 million, up 23% on aggregate ARM and Artisan revenues of $83.6 million reported in Q1 2004 - combined business remains on track for at least 20% dollar revenue growth in 2005
CAMBRIDGE, UK, 19 April 2005-ARM Holdings plc [(LSE: ARM); (Nasdaq: ARMHY)] announces its unaudited financial results for the first quarter ended 31 March 2005
HIGHLIGHTS (Figures in US GAAP)
First quarter ended 31 March 2005
- Total revenues in Q1 2005 at £55.0 million. Total dollar revenues* at $103.2 million, up 23% on aggregate ARM and Artisan revenues in Q1 2004
- At $79.2 million, dollar revenues* from the original ARM business up 6% sequentially and 27% ahead of Q1 2004. Licensing and royalty revenues up in dollar terms* 23% and 31% respectively on Q1 2004. Seventeen licenses for microprocessor cores signed in the quarter
- At $24.0 million, dollar revenues* from the Physical Intellectual Property Division (PIPD) up 12% on Q1 2004. Licensing and royalty revenues up in dollar terms* 6% and 28% respectively on Q1 2004. PIPD backlog remains near an historically high level at end Q1 2005
- PIPD license bookings in Q1 2005 include the first two instances of PIPD technology being licensed to existing ARM partners since completion of the merger
- Total operating expenses in Q1 2005 of £37.2 million, including acquisition-related charges of £6.0 million and other deferred stock-based compensation of £0.3 million
- Operating margin, excluding acquisition-related charges of £6.0 million and other deferred stock-based compensation of £0.3 million, at 32.4%(see note 4.1), comprising 31.7% in the original ARM business and 34.9% in PIPD
- Income before income tax at £12.5 million, including acquisition-related charges of £6.0 million and other deferred stock-based compensation of £0.3 million. Income before income tax, excluding these charges, at £18.8 million
- Consolidated cash position of £141.8 million(4.4) at 31 March 2005, compared to £128.5 million at the start of 2005, after adjusting for £14.3 million of transaction costs paid in Q1. Pro forma net cash generation of £13.2 million in the quarter(4.6)
- Earnings per fully diluted share in Q1 2005 of 0.6 pence (3.6 cents per ADS**). Earnings per fully diluted share, before acquisition-related charges of £6.0 million and other deferred stock-based compensation of £0.3 million, at 1.0 pence(4.7) (5.4 cents per ADS**)
* Dollar revenues are based on the group's actual dollar invoicing, where applicable, and using the rate of exchange applicable on the date of the transaction for invoicing in currencies other than dollars. Approximately 95% of invoicing is in dollars
** Each American Depositary Share (ADS) represents three sharesCommenting on the first quarter results, Warren East, Chief Executive Officer, said:
"I am pleased to announce that the integration of Artisan and ARM is progressing to plan and that the momentum in the business continues, with dollar revenues up 23% on the aggregate ARM and Artisan revenues in Q1 2004. We are well placed to capitalise on the opportunities that the combination of ARM and Artisan brings and are encouraged that Q1 has seen the first instances of existing ARM licensees taking Artisan's physical IP. This progress gives us further confidence that both underlying businesses can achieve at least 20% growth in dollar revenues as outlined at our Q4 results."
Tim Score, Chief Financial Officer, added:
"Operating margins in excess of 30% in both the original ARM business and in the Physical IP division demonstrate the robust condition of the business as a whole as well as the attractive business model and financial profile of the enlarged ARM group."
Operating and financial review
(US GAAP unless otherwise stated)
Market conditions, current trading and prospects
We expressed confidence in January that, notwithstanding a likely flatter trading environment in 2005 for the semiconductor industry as a whole, both the original ARM business and PIPD were capable of growing dollar revenues by at least 20% in 2005 (assuming a normalized base for PIPD in calendar 2004 of approximately $95 million).
Total group dollar revenues in the first quarter of 2005 are 23% ahead of the aggregate revenues reported by ARM and Artisan in Q1 2004 with the original ARM business up by 27% and PIPD 12% ahead. Having accomplished the integration objectives that we set out to achieve in Q1, including the combination of the ARM and PIPD sales forces into one integrated regionally-based worldwide sales force, we remain confident of achieving dollar revenue growth of at least 20% in both underlying businesses in the full year 2005, with license revenues underpinned by both a healthy order backlog and a robust sales opportunity pipeline, good underlying momentum in royalty revenues and continued steady growth in development systems revenues.
Total revenues
Total revenues for the first quarter of 2005 amounted to £55.0 million. In US dollar terms*, first quarter revenues of $103.2 million were 23% up on the aggregate ARM and Artisan revenues of $83.6 million(4.10) in Q1 2004. The effective US dollar to sterling exchange rate for ARM in Q1 2005 was $1.875 compared to $1.80 in Q4 2004 and $1.78 in Q1 2004.
License revenues
Total license revenues in the first quarter were £24.7 million representing 45% of group revenues. License revenues comprised £16.3 million from the original ARM business and £8.4 million from PIPD. In US dollar terms*, license revenues from the original ARM business of $30.0 million in Q1 2005 were 4% ahead of Q4 2004 and 23% up on Q1 2004.
Seventeen licenses for microprocessor cores were signed in the first quarter of 2005. Eight new partners took a total of nine licenses, comprising two per use licenses from the ARM7™ family, five per use licenses from the ARM9™ family, one license for the SC100™ processor and one license for the next-generation Cortex™-M3 processor. Five existing partners took licenses for a further eight cores, comprising one derivative and one upgrade to the ARM7 family, one derivative and two upgrades to the ARM9 family and three upgrades to the ARM11™ family.
Following a 15% sequential increase in the ARM standalone order backlog in Q4 2004, the backlog at the end of Q1 is some 10% lower than at the end of Q4. Based on the sales opportunity pipeline, however, we remain confident that the positive trend in order backlog experienced in recent quarters will continue in to the medium term.
Royalty revenues
Total royalty revenues in the first quarter were £20.9 million representing 38% of total group revenues. Royalty revenues comprised £16.8 million from the original ARM business and £4.1 million from PIPD. In US dollar terms*, royalty revenues from the original ARM business of $31.6 million in Q1 2005 were 7% up sequentially and 31% up on Q1 2004.
Royalty revenues recognized in the original ARM business in the quarter ended 31 March 2005 (we receive and report royalty data one quarter in arrears) were $31.6 million based on unit shipments of 389 million, up 40% on the same period a year ago. The average royalty rate per unit reported in the first quarter was 8.1 cents compared to 8.0 cents per unit in Q4 2004. Of the total unit shipments reported in the first quarter, 29% related to units based on ARM9 family technology. Unit shipments based on the ARM926EJ-S™ microprocessor accounted for approximately 5% of total shipments in the quarter.
In Q1 2005, the proportion of total unit shipments accounted for by the wireless segment was 65%, representing 252 million units. The 35% relating to the aggregate shipments in all sectors other than wireless represents 137 million units in Q1 2005, an increase of 68% on Q1 2004. In Q1 2005 unit shipments have grown particularly strongly compared to Q4 2004 in the consumer and storage segments.
Development Systems and Service revenues
Sales of development systems were £5.7 million, representing 10% of total group revenues. In US dollar terms, development systems revenues were $11.0 million this quarter, 6% up sequentially and 53% up on Q1 2004. Consistent growth in recent quarters in development systems sales has been enhanced by sales of electronic system level (ESL) tools following the acquisition of Axys in the second half of 2004. Service revenues were £3.6 million, representing 7% of total group revenues.
PIPD developments
Total revenues earned by PIPD in Q1 2005 were $24.6 million (before a reduction of $0.6 million as a result of fair value adjustments made to deferred revenue on acquisition), compared to $15 million in Q4 2004 and $21.4 million in Q1 2004. Reported revenues in Q1 2005 comprised license revenues of $16.2 million and royalty revenues of $7.8 million, compared to $7.0 million and $8.0 million respectively in Q4 2004.
License bookings in Q1 2005 include the first two instances, since the combination of ARM and Artisan, of PIPD technology being licensed to existing ARM semiconductor partners. The order backlog at the end of Q1 2005 remains near an historically high level.
As with the original ARM business, PIPD receive and report royalty data one quarter in arrears. PIPD also carries out an ongoing dialogue with its foundry partners to ensure that royalty payments are accurate and up to date. This process includes regular audits being carried out by third party accounting firms. As a result, reported quarterly royalty revenues will often include amounts which relate to shipments made in prior periods ("catch-up" royalties). Such amounts are hard to forecast and have varied significantly from quarter to quarter. Royalty revenues in Q1 2005 of $7.8 million included approximately $0.8 million of "catch-up" royalties, implying a base level of royalties of $7 million. The base level of royalties has been growing steadily over recent quarters.
The integration of ARM and Artisan is progressing to plan. The ARM and Artisan sales teams have been combined into one regionally structured worldwide sales force and have achieved the first sales of PIPD licenses to existing ARM semiconductor partners. We have also rationalized and consolidated offices and support activities, including the closure of the ARM office in Los Gatos, California and relocated its employees to Artisan's Sunnyvale facility, the new headquarters for ARM in the US. Further, we have started to expand the capability of the Bangalore Design Centre acquired as part of the Artisan transaction by supplementing the PIPD engineering team already there with 22 new employees, who have been hired in the last 6 weeks, to work on engineering and support activities relating to the original ARM business, including embedded software, CPU design verification, customer support and engineering work for development systems. We plan to grow headcount further in Bangalore during 2005.
We have also introduced the first innovative business model to result from the combination of ARM and Artisan, with the announcement on 11 April 2005 of the launch of the ARM DesignStart™ programme, a potentially significant broadening of the reach of ARM's existing Foundry Programme, which allows developers access to the ARM7TDMI® processor for the TSMC, UMC, SMIC and Chartered Semiconductor process technologies at no initial charge. By leveraging the web-based distribution channel developed by Artisan, developers are able to gain early access to ARM technology to complete the design process all the way through to chip-level verification. Once the design is finished and ready for fabrication, a single-use design license can be purchased from ARM to receive a full set of deliverables, enabling tape out and manufacture at any of the supported foundries. The initial response to the launch of DesignStart has been very encouraging. ARM launched the original Foundry Programme in 2000, since which time 90 single use licenses have been signed with 68 companies.
Following the completion of the ARM and Artisan combination at the end of 2004 and the achievement of our initial integration objectives in the first quarter, the PIPD management organization has been developed to reflect PIPD's status as a semi-autonomous division of ARM rather than a standalone public company.
Mark Templeton, former President and Chief Executive Officer of Artisan, who joined the Board of ARM Holdings plc in December 2004, becomes Chief Strategy Officer of the ARM group and President of ARM Inc and will focus on the strategic development of ARM as a whole and be closely involved in the development of ARM's profile in the US, both within the semiconductor industry and within financial markets.
Brent Dichter, formerly the VP of Engineering at Artisan, has been appointed as the General Manager of PIPD. Brent reports to Tudor Brown, Chief Operating Officer of ARM.
Gross margins
Group gross margins for the first quarter were 89%, comprising 93% for the original ARM business and 75% for PIPD. The increased gross margin compared to Q4 2004 in the original ARM business reflects the decreased proportion of license revenues earned in Q1 from strategic relationships which include revenue sharing arrangements.
Operating expenses
Total group operating expenses in the quarter were £37.2 million, including acquisition-related charges of £6.0 million and other deferred stock-based compensation of £0.3 million. Excluding these charges, operating expenses in the quarter were £30.9 million of which £25.9 million related to the original ARM business and £5.0 million to PIPD.
Total research and development expenses were £14.7 million in Q1 2005, representing 27% of revenues. This compares to £13.0 million or 31% of revenues in Q4 2004 for the original ARM business. Total sales and marketing costs in Q1 2005 were £8.3 million or 15% of revenues compared to £6.3 million or 15% of revenues in Q4 2004 for the original ARM business. Total general and administration expenses in Q1 2005 were £7.8 million, representing 14% of revenues compared to £6.8 million or 16% of revenues in Q4 2004 for the original ARM business.
Operating margins
Operating margin in Q1 2005 was 20.9% compared to 8.2% in Q4 2004. Operating margin, excluding acquisition-related charges of £6.0 million and other deferred stock-based compensation of £0.3 million, was 32.4%(4.1) in Q1 2005 compared to 29.4%(4.2), excluding non-recurring and acquisition-related charges of £8.2 million and other deferred stock-based compensation of £0.6 million, in Q4 2004 for the original ARM business. Operating margin of 32.4% in Q1 comprises 31.7% in the original ARM business and 34.9% in PIPD.
Interest receivable
Total interest receivable in Q1 2005 was £1.0 million, compared to £1.9 million in Q4 2004. The reduction arises from lower average cash balances in Q1 compared to Q4 2004 as the total cash paid in consideration and transaction expenses on the acquisition of Artisan at the end of 2004 was greater than the cash acquired with Artisan. Further, of the net group cash position of £141.8 million at 31 March 2005, £83.7 million was held in US dollar bank accounts which typically earn interest at lower rates than sterling cash deposits.
Earnings and taxation
Income before income tax in Q1 2005 was £12.5 million compared to £5.3 million in Q4 2004. Income before income tax, excluding acquisition-related charges of £6.0 million and other deferred stock-based compensation of £0.3 million, was £18.8 million. The group's effective tax rate under US GAAP in Q1 2005 was 27.6%, reflecting the availability of research and development tax credits in the UK and the US.
First quarter fully diluted earnings per share prepared under US GAAP were 0.6 pence (3.6 cents per ADS**) compared to earnings per share of 0.4 pence (2.4 cents per ADS**) in Q4 2004. Earnings per fully diluted share in Q1 2005, before acquisition-related charges of £6.0 million and other deferred stock-based compensation of £0.3 million, were 1.0(4.7) pence per share (5.4 cents per ADS**) compared to 1.1 pence(4.8) (6.4 cents per ADS**) in Q4 2004, before non-recurring and acquisition-related charges of £8.2 million and other deferred stock-based compensation of £0.6 million.
Balance sheet and cash flow
Intangible assets at 31 March 2005 were £419.8 million, comprising goodwill of £348.8 million and other intangible assets of £71.0 million, compared to £340.4 million and £74.6 million respectively at 31 December 2004. The increase in goodwill in Q1 2005 is due primarily to foreign exchange movements. Goodwill is no longer amortized under US GAAP but is subject to impairment on at least an annual basis. The other intangible assets are being amortized through the profit and loss account over a weighted average period of 5 years.
Accounts receivable at 31 March 2005 were £43.9 million, compared to £34.3 million at 31 December 2004 due primarily to the different timing profile of invoicing in Q1 2005 compared to Q4 2004. The allowance against receivables was £1.2 million at 31 March 2005 compared to £1.5 million at 31 December 2004. Deferred revenues were £21.8 million at the end of Q1 2005 compared to £21.4 million at 31 December 2004.
Pro forma net cash generation in the quarter, before cash costs of £14.3 million related to the acquisition of Artisan, was £13.2 million(4.6). The consolidated cash, cash equivalents, short-term investments and marketable securities balance was £141.8 million(4.4) at 31 March 2005.
Introduction of International Financial Reporting Standards (IFRS)
ARM reports results quarterly in accordance with US GAAP. At 30 June and 31 December each year, in addition to the US GAAP results, ARM has also disclosed results under UK GAAP. Following the introduction of IFRS with effect from 1 January 2005, ARM will continue to report quarterly results under US GAAP but will now disclose results additionally under IFRS at 30 June and 31 December. ARM will disclose IFRS numbers for the first time in July 2005 for the six month period to 30 June 2005.
The principal impact on ARM's results of the introduction of IFRS in the place of UK GAAP is expected to arise as a result of IFRS 2, whereby the fair value of employee stock options issued after 7 November 2002 and outstanding at 31 December 2004 will be charged to the profit and loss account. Under UK GAAP the fair value of stock options was not charged to the profit and loss account. ARM has, however, disclosed in the US GAAP section of its Annual Report since 1998, the effect on net income and earnings per share if the company had applied the fair value recognition provisions of FASB Statement No.123 ("Accounting for stock-based compensation") to stock-based employee compensation.
It is expected that ARM will continue to write off research and development expenditure to the profit and loss account as incurred under IFRS. Goodwill and other intangible assets are also reported differently under IFRS than under UK GAAP, with goodwill being capitalized but not amortized and separately identifiable intangible assets being capitalized on acquisition and amortized over their estimated useful lives. The IFRS treatment is similar to the current treatment under US GAAP.
ARM had 1,179 full time employees at the end of Q1 2005, compared to 1,171 at the end of 2004. At 31 March 2005, the group had 541 employees based in the UK, 458 in the US, 81 in Continental Europe, 59 in India and 40 in the Asia Pacific region.
Legal matters
In May 2002, Nazomi Communications, Inc. filed suit against ARM alleging willful infringement of Nazomi's US Patent No. 6,332,215. ARM answered Nazomi's complaint in July 2002 denying infringement. ARM moved for summary judgment and a ruling that the accused technology does not infringe. In September 2003, the United States District Court of Northern California granted ARM's motion, holding that the accused technology does not infringe Nazomi's patent. Nazomi appealed the District Court's ruling. On 7 September 2004, the Court of Appeals for the Federal Circuit heard the appeal.
On 11 April 2005, the Court of Appeals sent the case back to the District Court for a more detailed analysis of the original claim construction and further analysis in support of its non-infringement ruling. The Court of Appeals did not reject the District Court's ultimate conclusion, but held that the District Court had not provided sufficient information for a proper appellate review. Based on legal advice received to date, ARM has no cause to believe that the effect of the original ruling by the District Court will not be upheld.ARM Financial tables
ARM Holdings plc 2005 Results For The Quarter Ended 31 March 2005 (222Kb PDF)
About ARM
ARM designs the technology that lies at the heart of advanced digital products, from wireless, networking and consumer entertainment solutions to imaging, automotive, security and storage devices. ARM's comprehensive product offering includes 16/32-bit RISC microprocessors, data engines, 3D processors, digital libraries, embedded memories, peripherals, software and development tools, as well as analog functions and high-speed connectivity products. Combined with the company's broad Partner community, they provide a total system solution that offers a fast, reliable path to market for leading electronics companies. More information on ARM is available at http://www.arm.com/
The results shown for Q1 2005 are unaudited.
The results for ARM for Q1 2005 and previous quarters as shown reflect the accounting policies as stated in Note 1 to the US GAAP financial statements in the Annual Report and Accounts filed with Companies House in the UK for the fiscal year ended 31 December 2004 and in the Annual Report on Form 20-F for the fiscal year ended 31 December 2003.
This document contains forward-looking statements as defined in section 102 of the Private Securities Litigation Reform Act of 1995. These statements are subject to risk factors associated with the semiconductor and intellectual property businesses. When used in this document, the words "anticipates", "may", "can", "believes", "expects", "projects", "intends", "likely", similar expressions and any other statements that are not historical facts, in each case as they relate to ARM, its management or its businesses and financial performance and condition are intended to identify those assertions as forward-looking statements. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a variety of variables, many of which are beyond our control. These variables could cause actual results or trends to differ materially and include, but are not limited to: failure to realize the benefits of our recent acquisitions, unforeseen liabilities arising from our recent acquisitions, price fluctuations, actual demand, the availability of software and operating systems compatible with our intellectual property, the continued demand for products including ARM's intellectual property, delays in the design process or delays in a customer's project that uses ARM's technology, the success of our semiconductor partners, loss of market and industry competition, exchange and currency fluctuations, any future strategic investments or acquisitions, rapid technological change, regulatory developments, ARM's ability to negotiate, structure, monitor and enforce agreements for the determination and payment of royalties, actual or potential litigation, changes in tax laws, interest rates and access to capital markets, political, economic and financial market conditions in various countries and regions and capital expenditure requirements.
More information about potential factors that could affect ARM's business and financial results is included in ARM's Annual Report on Form 20-F for the fiscal year ended 31 December 2003 including (without limitation) under the captions, "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations," which is on file with the Securities and Exchange Commission (the "SEC") and available at the SEC's website at www.sec.gov. and in the Listing Particulars dated 19 November 2004.
The financial information contained in this announcement does not constitute statutory accounts within the meaning of Section240 (3) of the Companies Act 1985. Statutory accounts of the Company in respect of the financial year ended 31 December 2004 have been delivered to the Registrar of Companies, upon which the Company's auditors have given a report which was unqualified and did not contain a statement under Section 237(2) or Section 237(3) of that Act.ARM and ARM7TDMI are registered trademarks of ARM Limited. ARM7, ARM9, ARM926EJ-S, ARM11, SC100, Cortex and DesignStart are trademarks of ARM Limited. Artisan Components and Artisan are registered trademarks of ARM Physical IP, Inc., a wholly owned subsidiary of ARM. All other brands or product names are the property of their respective holders. ARM refers to ARM Holdings plc (LSE: ARM and Nasdaq: ARMHY) together with its subsidiaries including ARM Limited, ARM Inc., ARM Physical IP Inc., Axys Design Automation Inc., Axys GmbH; ARM KK, ARM Korea Ltd, ARM Taiwan Ltd, ARM France SAS, ARM Consulting (Shanghai) Co. Ltd.; ARM Belgium NV.; and ARM Embedded Solutions Pvt. Ltd.
Search Silicon IP
Arm Ltd Hot IP
Related News
- ARM Holdings plc Reports Results For The First Quarter Ended 31 March 2011
- ARM Holdings plc Reports Results for the First Quarter Ended 31 March 2010
- ARM Holdings plc Reports Results for the First Quarter Ended 31 March 2009
- ARM Holdings plc Reports Results For The First Quarter Ended 31 March 2008
- ARM Holdings plc Reports Results For The First Quarter Ended 31 March 2007
Breaking News
- CXL Consortium and Gen-Z Consortium Announce MOU Agreement
- Strategic Investment of NXP in Kalray
- eInfochips to Exhibit and Present at Design & Reuse IP-SoC Silicon Valley 2020
- Leading Industry Veteran Joins SiFive as Chief Financial Officer
- Allegro DVT AV1 Encoder and Decoder Hardware IPs Embedded in Products by End of 2020
Most Popular
- Intel shines amidst the carnage of the 2019 semiconductor market
- Synopsys Expands Collaboration with Broadcom for 7nm and 5nm Designs
- COVID-19 To Have Significant Effect on Worldwide Semiconductor Market in 2020, According to IDC
- Allegro DVT AV1 Encoder and Decoder Hardware IPs Embedded in Products by End of 2020
- Silex Insight launches Chinese OSCCA high performance (400 Gbps) SM4 Crypto Core
|E-mail This Article
|Printer-Friendly Page


text:
Artwork Shop
Title: HARMONY
Reference: SF4/17L
Price: £40 plus P&P
Original Mounted Artwork with double conservation mount size 270x270 mm overall
For more information or to buy please call Lyn on 01483 810555 or email.
Original artwork, each one very individual. with lots of "Bling". Please call us to place an order quoting the reference number. We can offer a framing service if required and are happy to discuss this with you.. P&P will be quoted at time of order.
( We accept most credit cards )
To avoid disappointment - call straight away.
Each piece of artwork is unique and can only be sold once!
( We accept most credit cards )

subset: commoncrawl


text:
Good news coming out of Dynamo camp this morning as striker Omar Cummings, who was acquired by Houston from the Colorado Rapids in December, has returned to training with the first team.
Cummings has been sidelined since the end of January after undergoing surgery on January 25 to repair a right knee injury. According to Houston Chronicle reporter Jesus Ortiz, Cummings hopes to be available for selection within the next two weeks, meaning that the Jamaican national team forward could make his debut in the Dynamo's March 23 home match vs. the Vancouver Whitecaps.
This will come as good to news to the Dynamo, who have a busy schedule over the next few weeks. If Houston earns the necessary result to get past Santos Laguna in the Champions League quarterfinals, they could be looking at seven games (MLS + CCL) in a span of four weeks.


text:
I blogged about a Canadian student's discovery of plastic-eating microorganisms last May. Just last month, another 16-year-old high school student (this time from Taiwan), Tseng I-Ching swept the world's largest science fair in the Peoples Choice Category at the Intel International Science & Engineering Fair (ISEF) for her discovery of a polystyrene-decomposing bacterium derived from mealworm beetles.
I-Ching vivisected more than 500 mealworm beetles to isolate the single bacterium that allows the mealworm to digest one of the most troublesome forms of waste on the planet — Styrofoam. For her discovery, I-Ching was awarded the top prize in the microbiology category along with four other prizes.
The girl, nicknamed "Frog," says her main career objective is to become a microbiologist and "save the world." To that end, she spent the better part of her school year skipping classes to develop her innovative project isolating the "red bacteria" with the support of two leading microbiology scholars in Taipei.
Her hard work got her in trouble at school (at one point she almost stopped her research project due to pressure from her school teachers) but she carried on and is now grateful she stuck with her passion. As she says, "I love to observe and find wonder from nature. I love to solve questions. This is how I started my project."
There have been two successful bacteria-based solutions for styrene decomposition developed at the Department of Biotechnology in Tottori, Japan, as well as the Department of Microbiology at the National University of Ireland. Both rely upon a patented soil organism called Pseudomonas putida.
Polystyrene is the bad boy of the petrochemical industry. In addition to the highly toxic chemicals required to manufacture polysterene products (namely benzene), expanded polystyrene foam requires ozone-depleting HCFC's (CFC's used to be used to make Styrofoam, but they have been banned for the most part). Then once disposed, it basically NEVER decomposes. It does however break apart into smaller granules, but because of its light weight, those particles quickly become both airborne and waterborne, where they wreck havoc on the ocean food chain.
The U.S. disposes of about 25 billion Styrofoam cups every year and tons more extruded and expanded polystyrene packaging material. It's a big, big problem. Biodegradable alternatives are now hitting the market, but hopefully Tseng I-Ching's small discovery will help give to give existing Styrofoam waste a proper burial.


text:
Request for a preliminary ruling from the Cour administrative (Luxembourg) lodged on 31 May 2019 — State of the Grand Duchy of Luxembourg v L
(Case C-437/19)
Language of the case: French
Referring court
Cour administrative
Parties to the main proceedings
Applicant: State of the Grand Duchy of Luxembourg
Defendant: L
Questions referred
1. Must Article 20(2)(a) of Directive 2011/16 1 be interpreted as meaning that where a request for exchange of information formulated by an authority of a requesting Member State designates the taxpayers to which it relates simply by reference to their status as shareholders and beneficial owners of a company, without those taxpayers having been identified by the requesting authority in advance, individually and by name, the request satisfies the identification requirements laid down by that provision?
2. If the answer to the first question is in the affirmative, must Article 1(1) and Article 5 of that directive be interpreted as meaning that the standard of foreseeable relevance may be met, if the requesting Member State, in order to establish that it is not engaged in a fishing expedition, despite the fact that it has not individually identified the taxpayers concerned, provides a clear and sufficient explanation evidencing that it is conducting a targeted investigation into a limited group of persons, and not simply an investigation by way of general fiscal surveillance, and that its investigation is justified by reasonable suspicions of non-compliance with a specific legal obligation?
3. Must Article 47 of the Charter of Fundamental Rights of the European Union be interpreted as meaning that, where
a person who has had imposed upon him by the competent authority of a Member State an administrative financial penalty for non-compliance with an administrative decision, requiring him to provide information in connection with an exchange of information between national tax authorities pursuant to Directive 2011/16, where the national law of the requested Member State does not make provision for an action to be brought against the latter decision, and where the person concerned has challenged the legality of that decision within an action brought against the financial penalty, and
has only obtained disclosure of the minimal information referred to in Article 20(2) of Directive 2011/16 in the course of the judicial procedure set in motion by the bringing of that action,
that person is entitled, in the event of a definitive incidental finding upholding the validity of the decision requiring the requested information and of the decision imposing a fine on him, to a period of grace for the payment of that fine, so that he has an opportunity, having thus been given disclosure of the material supporting the contention — definitively accepted by the competent court — that the test of foreseeable relevance is met, to comply with the decision requiring the requested information?


text:
WASHINGTON, June 11 (UPI) -- The U.S. Supreme Court Monday declined to second-guess anti-terrorism policies, denying appeals by seven Guantanamo Bay detainees.
The court also rejected an appeal by Jose Padilla, the U.S. citizen who was declared an enemy combatant for allegedly planning a radiological attack on the United States and was ater convicted in federal court of conspiring to kill.
The decisions came just one day before the fourth anniversary of a decision that gave Guantanamo prisoners the right to seek release but left the lower courts to deal with the issue, ScotusBLOG noted.
Without dissent, the court left it to the D.C. Circuit Court to have the final say on 169 foreign nationals still being held at Guantanamo.


text:
Technical Paper
Total Thermal Management of Battery Electric Vehicles (BEVs)
The key hurdles to achieving wide consumer acceptance of battery electric vehicles (BEVs) are weather-dependent drive range, higher cost, and limited battery life. These translate into a strong need to reduce a significant energy drain and resulting drive range loss due to auxiliary electrical loads the predominant of which is the cabin thermal management load. Studies have shown that thermal sub-system loads can reduce the drive range by as much as 45% under ambient temperatures below −10 °C. Often, cabin heating relies purely on positive temperature coefficient (PTC) resistive heating, contributing to a significant range loss. Reducing this range loss may improve consumer acceptance of BEVs. The authors present a unified thermal management system (UTEMPRA) that satisfies diverse thermal and design needs of the auxiliary loads in BEVs.


text:
Warwick, Massachusetts
|This article is a stub. Help us to expand it by contributing your knowledge. For county and town page guidelines, visit U.S. County Page Content Suggestions.
Warwick is a town in Massachusetts. It was formed in 1763 and was previously called (Roxbury Canada Plantation). It can be found in Franklin county and is a part of the Greenfield (Deerfield) registry of deed district. For more information, contact the county at 12 Athol Rd., Warwick 01364. On the attached map, Warwick is shown as 8 in Franklin county.
For information about the state of Massachusetts see Massachusetts Family History Research.


text:
Culliver getting sensitivity training post-Super Bowl
NEW ORLEANS — As comedian Artie Lange reflected Saturday on the controversy he stirred this week with San Francisco 49er Chris Culliver, the publicist for the cornerback says sensitivity training will start post-Super Bowl for the anti-gay remarks the player made.
Culliver is scheduled to begin working with The Trevor Project, an organization that provides crisis and suicide intervention to lesbian, gay, bisexual and transgender youth, according to his public relations representative, Theodore Palmer.
"It's just an opportunity for him to learn about his comments and educate himself about the LGBT community, and grow," Palmer said. "It's the first step in learning about his words."
On media day Tuesday, Lange had raised the issue with Culliver about whether he would accept a teammate who was gay. The second-year player said he would not accept that and added that if the 49ers had any homosexual players, they should leave.
"When I asked the question I was just joking around, and then he wouldn't stop talking," Lange told USA TODAY Sports at the DirecTV Celebrity Beach Bowl here on Saturday. "I said to myself, 'I gotta play this tape, but he's a young kid and doesn't know any better.'
"Yeah, in today's world I knew it would get a big reaction. It seemed to get a little crazier than I thought."
Culliver's anti-gay comments drew an immediate rebuke from the team and an apologetic statement from the player Wednesday, followed by an hour-long Q&A on the subject during player availability with media Thursday.
MORE:Culliver apologizes for homophobic remarks
Meanwhile, the It Gets Better Project for gay rights has pulled from its website an ad made with some 49er players who subsequently said they thought they had been involved with only an anti-bullying video.
When shown the ad, defensive tackle Isaac Sopoaga and linebacker Ahmad Brooks told USA TODAY Sports they had no idea it was to support gay rights.
All this arising from what Lange thought was a harmless question.
"It ruined (Culliver's) week and I don't feel good about that. But if that's how he really felt and this helped it get out there, maybe he'll change it," Lange said.
"I'm a stupid comedian. I don't think he knew who I was. I looked homeless, quite frankly."
Palmer also said Culliver will spend time volunteering at a crisis center in San Francisco.
Contributing: Wire reports


text:
I hardly blogged at all in October. Ooops. It was a good month! Some fun things happened!!
Jane and I went to the Joshua Radin/Matt Nathanson concert. It did not disappoint. Sometimes I wonder why on earth I see Joshua Radin in concert so many times. Then I see him live and I remember. He's just SO GOOD. He only played a few songs because he was the opener for Matt Nathanson. I had seen Matt Nathanson years ago and had forgotten how entertaining he is!!! Joshua is really quiet and relaxed. Matt Nathanson is a crack up. He's super funny and full of energy. He is so fun to see in concert. If you have the chance, go!!
The second weekend on October, Jane and I went to Rexburg to visit Jen!! Rexburg weekends are always so much fun. It's great to see Jen-I wish she didn't live so far!!! We did our annual advent calendar craft. And I actually finished my whole thing! Miracle!!! They turned out super cute and I'm excited to use it this year! We also made some delicious Thai food. Whenever I go to Rexburg, I know we will eat delish things, that's just how they roll up there.
I spent nearly a week in St George for work. It was actually really nice to have a little solo vacation. By the end of the week though, I was ready to be back with people again and back to my real life.
October also included lots of Junior League meetings and lots of Jeremy time. Both good things. The weekend before Halloween, I went with Jeremy to the Macklemore concert. I was pleasantly surprised with how good they were!! They put on a great show and were great performers. We had a great time! We also made it to a Jazz game. They got a new jumbo tron screen and jumbo is an understatement. The new screen is enormous. I think I talked about the screen for at least the first quarter of the game.
October was a good month! It just flew by and now it's time for Thanksgiving, Christmas, New Years and then my birthday! The holiday season is here!!!
On Halloween we had a little lunch and party at work. It still is so funny to me that people dress up for work. My coworkers are super fun and get really into it which makes it fun. Dressing up for work was actually the only time I dressed up this year.
October was a good month! It just flew by and now it's time for Thanksgiving, Christmas, New Years and then my birthday! The holiday season is here!!!


text:
So the fellas and I are packing up and moving several states away this week — on Friday or Saturday, depending on how packing and loading up the truck goes — and as a result I have no dadgummed clue where my copy of Susan Bordo's Unbearable Weight is. It may be in the garage (appropriately off-the-floor and well-cared-for, I hasten to add; for I am not a hater of books, and I would wither if any of the awesome Shapeling librarians or librarians-to-be gave me the hairy eyeball) or it may be in a pile of somethings, or under something, or in with the cookbooks, I'm just not sure.
If I had access to the book, I would here post something intelligent and pertinent about the Dainty Little Bite — that culturally-approved way for women to have appetites. Because I've been thinking a lot about appetites, as I expect most of you have noticed; and I've been thinking lately about the Dainty Little Bite in particular. And I would love to rehash what Susan Bordo has already said, and use an excerpt as conversation fodder. (Note to Susan Bordo, if you're reading: You are my fantasy Famous Shapeling. I love to imagine that you read here. I like to think that that's actually entirely possible, and that one day we'll discover that you're a regular commenter here with a wickedly clever little alias that you chose so that you could help collaborate on some of the more ribald contributions that the SP community has made to humanity over the years… the parodies, the Douchehoundings, etc. But a friend of mine from college has now gone and ACTUALLY STUDIED WITH YOU in grad school, and she tells me that in her opinion you'd have no qualms about commenting here under your own name, because you're fearless like that. Sigh. Reality, why must you get in the way of all my cherished fantasies?!)
But, as established, the book is not handy. So here are my off-the-cuff thoughts and questions about the Dainty Little Bite. First, it really has cognates in other appetites, no? (I'm just thinking for example of all those advertisements, mostly ones directed at heterosexual doods… where a woman is pictured with the product, the camera angle is from above and looking down on her, she's looking up playfully — childishly let seductively — and her mouth is half-open. Isn't that kind of the Dainty Little Bite of sexual appetite? Or have I got it all backwards and inside-out?)
Related to that: is it just me, or is the Dainty Little Bite not basically a shorthand for "I have just enough desire to indulge my appetites when you would find it titillating and/or useful, but not enough desire to spur me to set my own terms"?
And third, how is the Dainty Little Bite situated by whiteness and by middle class identity? Having seen the racist and classist ways in which virtuous eating functions among white middle-class people* I wouldn't be surprised to learn that it's thoroughly situated by whiteness and middle class anxiety/internalized superiority. But I'm a white straight cis middle-class chick. For me, the DLB goes all the way down, so far that I can't see where it starts and where it stops.
All these may be obvious, and all may have been stated better (BY SUSAN BORDO, PROBABLY, which is why I wish I could put my hands on the damn book). Anyway, may we talk about it? (I feel a twinge of guilt here for not having, you know, a strong and assertive thesis statement — "In this blog post, I shall argue that…" etc. — but honestly, I'd more like to know what you all think. Plus, I'm in the middle of a move, and I'm rather pleasantly surprised I can put together sentences at all beyond "The thus-and-such goes in the this-or-that.")
Sooo, discuss! (Please? And thanks.)
*-Recently someone cold-called one of my husband's colleagues and asked him if their church group could bring "fresh fruits and vegetables" to their neighborhood in the "inner city." He was like, "How did you get this idea? Do you know anyone in our neighborhood? Did anyone call you and ask for your gracious help?" No no no, they just heard from other white crunchy virtuous eaters, and saw on the teevee, that there were poor people of color in the inner city who were miserable wretches in need of produce. So they decided to help. Without being asked. Which straightaway reminded me of the clip from Sesame Street where some kids are just eating their lunches, minding their own business, and are interrupted by the obnoxious and intrusive Captain Vegetable… who bursts in and sings "It is I, Captain Vegetable! With my carrots! And my celery!" Ah, Sesame Street. Always so ahead of its day. I think I'm going to start humming this now anytime someone starts plotting to save the world from types of eating which they find icky-poo.


text:
IBM Now Offers ATI's High-End FireGL V7100 Workstation Graphics Accelerator in the IBM IntelliStation Line
ATI Builds on Success in Entry-Level Workstation Graphics
ATI Technologies Inc. today announced that IBM has selected the powerful FireGL? V7100 high-end workstation graphics accelerator for the IBM IntelliStation Pro line. Having previously selected the FireGL? V3100 for its IBM IntelliStation M Pro, ATI continues to build on its momentum in the entry-level and mobile workstation graphics markets and is now gaining ground in the high-end with today's announcement of the refreshed IBM IntelliStation M Pro and Z Pro products.
"Having selected the FireGL V7100 for the IntelliStation M Pro 6225 and Z Pro 6223, IBM now offers cost-effective systems for both entry-level and high-end workstations with ATI graphics," said Julie Irving, IntelliStation Pro Marketing Manager, IBM. "By broadening our offerings of ATI workstation graphics, customers can be confident that IBM workstations give them the performance, stability and reliability that they demand, regardless of their budget."
"ATI's momentum in the workstation market continues to grow, as important partners like IBM recognize the performance benefits of our products to their users," said Dave Rolston, Vice President and General Manager of Workstation and Embedded Products, ATI. "By continuing to focus on the needs of our engineering and creative design customers who rely on workstation graphics day-in and day-out, ATI has made a significant move forward with the transition to PCI Express."
The PCI Express-based FireGL V7100 maximizes the high-bandwidth bus to deliver phenomenal speed and image quality for real-time visualization and design creativity. With outstanding performance and stability, the FireGL V7100 features 256 MB of GDDR3 unified graphics memory, 16 pixel pipelines and 6 geometry engines and dual display support via two DVI outputs creating an immersive work environment.
ATI's FireGL products are supported by a unified driver, which is tested and certified by professional 3D ISV partners, making system administration and upgrades cost effective and simple. All FireGL products come with a three year warranty and unlimited direct access to a dedicated workstation technical support team.
For more information about ATI's FireGL product line, visit www.ati.com/FireGL


text:
Looks like the shorts are getting worried
Looks like the shorts are getting worried
LOL.. I noticed it yesterday. :-)
Started reading, but after a few sentences, I could be bothered.
A smelly mix of broken arguments (well put).
I should be "I could _not_ be bothered"
The same sort of nonsense was used against the Prius over 5 years ago.
It was based on very old invalid data. I'm not going to follow through on this article, as it's just more of the same.
I am quite sure that pollution is smaller during use of vehicle. But how could I know that pollution is higher/same/smaller during production. Which research can I trust?
And especially what should I say to my friends (or random folks) if they say EV is so far more dirty during production stage? If this research was lying tell me why? (I wish they was lying/not telling all, but I am not sure)
I am big EV fan.
As I read the above comments I could only think of a certain John Peterson.
LOL as I go to the link and he wrote it...
Blah blah blah old fart
well, I have to remember this name, so I can skip his articles :)


text:
MC Yan challenges the Hong Kong government to come clean about the city's air quality. Greenpeace have been pushing the government to update the way it assesses and reports air quality. The government have been using the same air quality standard for 20 years and it's time to update that to meet air quality standards recommended by the World Health Organisation and reflect the cit's true air quality.
MC Yan and Greenpeace East Asia challenge the Hong Kong government to tell the truth about the city's air pollution.
1 - 12 of 64 results.


text:
Alton Brown Calls Out Amazon's Alleged Wasteful Packaging
A disappointed Alton Brown just put Amazon on blast. The "Cutthroat Kitchen" host bought 10 new pie pans off the ecommerce site, and he claims each one showed up in its own separate box. Although he was recently crowned the most influential famous foodie on Twitter, Brown took to Instagram instead to express his disdain.
"Dear Amazon, I ordered 10 pie pans - little metal pie pans. You didn't have to send each one in its own box. This is why polar bears are dying," the 56-year-old said with a smile in a video. "Have a nice day."
The post picked up over 11,500 likes and 54,000 views in just three hours. Many of Brown's followers are supporting his position against unnecessary packaging.
"They're called Amazon because they need the trees from that rainforest to create more packaging," @astroboytoy said.
"Good move Alton. Sheesh, such a waste. Unless you save them for wrapping Christmas presents," @patriciapxm said.
Others are defending Amazon and suggesting that the boxes actually came from a third-party seller.
"Those are not Amazon boxes. That was a 3rd party seller/shipper on Amazon," @kylehildebrant said, to which @cmt.paparazzi.bling replied, "OMG someone else in this thread with a brain who doesn't jump the bandwagon. Thank God! For real though, some companies dictate how their items are packaged TO Amazon as they just fulfill orders. And the same people complaining about wasted packaging would be the first to complain about a damaged product if there wasn't ENOUGH packaging."
"Here's an idea… go to a store and buy. No wait, no packaging, no waste," @the_sb_tothe_max said.
The Daily Meal has reached out to Amazon for comment. Why does Alton Brown need 10 pie pans anyway? Likely for the sequel to "Good Eats," which is rumored to be hitting the small screen sometime this year. The original series, and Brown's claim to fame in the food world, first aired in July 1998. The final episode aired in February 2012. You'll never guess what he was doing before he was a Food Network star.


text:
Almora, the cultural capital of Kumaon, is one of the most popular hill stations of Uttarakhand. Situated at an altitude of 5417 ft. above sea level, it is perched over a 5 KM long horse saddle-shaped ridge of Kashaya mountain which is also mentioned in ancient Hindu scripture Manaskhand. It is surrounded by four mighty hills, each having temple on top of its peak- temples of Banardevi, Kasardevi, Sayahidevi & Dunagiridevi. Flowing alongside the city are rivers of Kosi (Kaushiki) & Suyal (Salmale). The snow-capped Himalayan Range can be seen in the background of the city.
We have best offers on Almora Holiday Packages from Mumbai, Almora Holiday from Mumbai, Almora Holiday Package from Mumbai, Holiday in Almora from Mumbai, Holiday to Almora from Mumbai, Holiday for Almora from Mumbai, Holiday with Almora from Mumbai.
Plan your upcoming Almora Holiday Packages with us. we'll take you to the one in every of the amazing and engaging tour destination in the world Almora!!!
Best Selling Holiday Packages of Almora from Mumbai


text:
Beaver Falls, PA – It didn′t look good early for senior quarterback David Girardi and the Geneva football team on Saturday at Bethany College. In the end, both Girardi and the Golden Tornadoes came out smelling like a rose as they rallied from 17 points down to pull out a 37-33 victory over the Bison. Girardi did most of the offensive damage for the Golden Tornadoes and for his efforts was named the NCCAA (National Christian College Athletic Association) football student-athlete of the week.
Girardi completed 20-31 passes for 372 yards and three touchdowns. He connected on a pair of 40 yard touchdowns before hooking up on an 88-yard touchdown pass, which was the third longest connection in school history. The 88 yard touchdown came in the fourth quarter and gave Geneva its first lead of the football game.
Geneva held Bethany out of the end zone from the one yard line on the final play of the game to preserve the victory and move its overall record to 2-2. For the season, Girardi is completing 64% of his passes for 1035 yards and seven touchdowns. He set a school record in 2009 by completing 62.3% of his passes.
Geneva College is a comprehensive Christian college of the arts, sciences and professional studies. Founded in the tradition of the Reformed Christian faith, Geneva prepares students to serve Christ in all areas of society: work, family and the church. Geneva College′s philosophy of education is based on the Foundational Concepts of Christian Higher Education. Geneva is a founding member of the Council for Christian Colleges & Universities (CCCU).
© Geneva College | All rights reserved


text:
As a longtime fan of the TV game show, Jeopardy!, I was fascinated when I watched an IBM supercomputer named Watson beat all-time Jeopardy! champions, two years ago this month.
I was particularly interested because my friend and colleague Larry Norton, Deputy Physician-in-Chief for Breast Cancer Programs, had previously alerted me to the fact that systems like IBM Watson could be harnessed to improve cancer care and research.
Combining the abilities to process massive amounts of data and use natural language processing could not only accomplish amazing things like winning Jeopardy!, it could also revolutionize care and research, accelerating progress for people with cancers.
A year after beginning work on this project, I remain as excited today as I was on day one.
Training Watson to Help Assist Medical Professionals
Over the past year, we at Memorial Sloan Kettering have worked with an IBM team to train Watson to help assist medical professionals in choosing treatments for lung and breast cancers.
We are sharing our knowledge and expertise in oncology, starting with hundreds of lung cancers, to help Watson learn everything it can about cancer care and how Memorial Sloan Kettering's experts use medical information and their experience in personalized cancer treatments.
Cancers are illnesses that continually humble doctors. A major leap forward in understanding these diseases over the past 40 years has been realizing how complex they are.
You may notice that I have been using the word cancers instead of cancer. I do it deliberately, as a reflection of what we have learned.
Doctors treating these illnesses now know how different they are from person to person. We need better ways to help us understand the complexity and variation of these diseases to improve care and research. Textbook and guideline-based treatments are a good place to start, but they can't address the many biological and other factors affecting the course and aggressiveness of cancers.
Current guidelines aren't granular enough to determine which treatments are best matched to the person with the illness. The guideline-recommended treatment may be chemotherapy, but how do you pick among ten or more possible chemo options? How do you choose the dosage? Which treatment frequency would work best?Back to top
The Power of Watson Technology
Oncologists learn ways to make these choices from their experience treating individual patients. That kind of wisdom is what the Memorial Sloan Kettering team is adding to IBM Watson. Our hope is to share our experience and knowledge, and, enabled by Watson technology, help physicians around the world understand and mine the subtleties of each person's illness.
We believe this strategy can take us one step closer to the goal of personalized care for every person facing cancer treatment.
The power of the technology is that it has the ability to take the information about a specific patient and match it to a huge knowledge base and history of treatment for similar patients. This process can help medical professionals gain important insights so that they can make more-informed decisions, evidence-based decisions, about which treatment to follow.
Watson's ability to mine massive quantities of data means that it can also keep up – at record speeds – with the latest medical breakthroughs reported in scientific journals and meetings.Back to top
A Milestone for Watson and Cancer Care
Today, I joined IBM and many other healthcare leaders in New York City to mark a milestone on the path to bringing the power of Watson to oncology care.
In collaboration with IBM, we unveiled the first commercially developed Watson-based cognitive computing system that is being taught by Memorial Sloan Kettering experts. We believe innovations like this one will help transform the quality and speed of care for patients and enhance research to lead to more cures.
One of the big goals for Memorial Sloan Kettering and IBM Watson is to improve the quality of care delivered to people with cancers, and for Watson to learn with every encounter, continually getting smarter.
Watson can also help to reduce the time and documentation required to get an approval to start treatment. It is an interesting aspect of the project that using a machine can actually allow doctors and nurses more time to focus on patients, rather than paperwork.
I'm sure that applying the Watson technology to oncology has the power to transform cancer care so that our healthcare providers can dedicate more time toward delivering the best possible care.Back to top
D O'Brien
Feb 8, 2013 • 3:01 PM
An IBMer is hoping to have Sloane Kettering's use of Watson harness the best treatment modalities for a patient with rare adenoidcystic carcinoma where expertise is difficult to locate. Patient has diagnosis of br ca but seeks comprehensive overview. It would be an honor to do so and showcase S-K and Watson. Thank you.
Benjamin Good
Feb 11, 2013 • 5:20 PM
This sounds fantastic, but how will other physicians and researchers gain access to it? It sounds like the technology will be bundled into it commercial products? Is there a possibility of building an Open Watson system that would be more accessible for researchers to both use and participate in training?
Memorial Sloan Kettering
Feb 12, 2013 • 9:08 AM
In reply to This sounds fantastic, but by Benjamin Good
Paul Reilly
Feb 28, 2013 • 1:10 PM
Dr. Kris got the treatment right for me without Watson. Being a patient with an unknown primary I was lucky Dr. Kris was my doctor. I'd like to see Watson try to beat Dr. Kris at diagnosing and determining treatment. Not sure who would win. Progress is good because if things didn't go well having a Watson would give good alternative advice and ideas.
Gary Sazer
Feb 28, 2013 • 3:08 PM
Dr. Kris saved my life more than 12 years ago by correctly diagnosing and treating the primary (which was inoperable and wrapped around my aorta) and and destroying a liver metastasis in the process. When my treatment was over the cancer was in total necrosis. If Watson could effectively clone Dr. Kris and help more doctors successfully diagnose and treat patients the Watson Thoracic Oncology program should be named "Kris".
Tatiana Araujo
Apr 1, 2014 • 2:29 PM
Memorial Sloan Kettering
Apr 1, 2014 • 5:25 PM
In reply to Are there any plans to make by Tatiana Araujo
Dear Tatiana, we anticipate that IBM Watson Oncology will be broadly available around the world. Memorial Sloan Kettering's role remains focused on "teaching" Watson Oncology about the latest cancer treatments. IBM will lead the effort to help oncologists anywhere access this tool. Thank you for your comment!
Diane Watson
Apr 17, 2014 • 1:49 AM
My mom has sc lung cancer, for 10 yrs, being cared for at Norwalk hospital cancer center, We have just now gotten her to agree to seek help at sloane Kettering. Being a Watson (IBM Family) I am praying to make appt w/you & have access to the Watson computer. My mothers Dr, will be avail in a week to release records to your amazing facility! I will be calling to set up new patient intake Thursday the 17th. Looking forward to start the process & treatment
Memorial Sloan Kettering
Apr 17, 2014 • 7:56 AM
In reply to My mom has sc lung cancer, by Diane Watson
Emily Nikoo
Sep 9, 2016 • 11:24 AM
The Watson MSK initiative is absolutely amazing! I recently saw how Gachon University is adopting it in Korea (http://finance.yahoo.com/news/gachon-university-gil-medical-center-0200…)
I have an interest in the Watson MSK work for a multitude of reasons, most importantly my husband is a patient at MSK (PCNSL, with Dr. Kaley) and secondly I am an engineer and work in big data. I realize the initiative is now 3-4 years old now. I was wondering, I see lung, breast and colorectal and then next gastric. Are you going to teach brain cancers as well? Any time soon? If so, who is the main doctor working it?
Thank you!
Memorial Sloan Kettering
Sep 14, 2016 • 3:10 PM
In reply to The Watson MSK initiative is… by Emily Nikoo
Dear Emily, we are sorry to hear about your husband's diagnosis. Unfortunately, we cannot say at this point if or when brain cancer will be part of our development plan, but we are continuing to build support for additional cancer coverage as part of our partnership with IBM Watson.
We wish your husband all our best for his continued care at MSK. Thank you for reaching out to us.
Oct 9, 2016 • 8:12 PM
Memorial Sloan Kettering
Oct 12, 2016 • 10:59 AM
In reply to When will Watson be involved… by Lise
Dear Lise, we are continuing to build support for additional cancer coverage as part of our partnership with IBM Watson. Prostate cancer is among the diseases being considered but we cannot confirm when support will be available within Watson for Oncology trained by Memorial Sloan Kettering. Thank you for reaching out to us.
Robert Stack
Oct 19, 2016 • 7:50 AM
Memorial Sloan Kettering
Oct 19, 2016 • 9:27 AM
In reply to Does Watson have the ability… by Robert Stack
Dear Robert, at present, Watson for Oncology trained by Memorial Sloan Kettering isn't ready to evaluate cases for patients with pediatric cancers. The physician team at Memorial Sloan Kettering continues to work with IBM Watson to develop support for additional cancers. Our physician experts are Watson's teachers, so even if we haven't trained Watson for Oncology on a given cancer, patients are welcome to schedule appointments for pediatric patients, including for second opinions, at MSK through our Department of Pediatrics at 212-639-5954. For more information about pediatric cancer care at MSK, please visit https://www.mskcc.org/pediatrics. Thank you for reaching out to us.